STOCK TITAN

Alkermes to Participate in the Stifel 2023 CNS Days

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

On March 15, 2023, Alkermes plc (NASDAQ: ALKS) announced its participation in a fireside chat at the Stifel 2023 CNS Days. The event will take place on March 29, 2023, at 9:00 a.m. ET (2:00 p.m. BST). The live webcast can be accessed on the Investors tab of Alkermes' website and will be available for 14 days post-event. Alkermes is a global biopharmaceutical company focused on neuroscience and oncology, offering products for alcohol and opioid dependence, schizophrenia, and bipolar I disorder. For more details, visit www.alkermes.com.

Positive
  • None.
Negative
  • None.

DUBLIN, March 15, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the Stifel 2023 CNS Days on Wednesday, March 29, 2023 at 9:00 a.m. ET (2:00 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Bernard
Investor Relations
+1 781 873 2402

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-stifel-2023-cns-days-301773137.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Stifel 2023 CNS Days?

Alkermes will participate in the Stifel 2023 CNS Days on March 29, 2023, at 9:00 a.m. ET.

How can I access Alkermes' fireside chat?

You can access the live webcast of Alkermes' fireside chat under the Investors tab on their website.

What is Alkermes' stock symbol?

Alkermes' stock symbol is ALKS.

What products does Alkermes develop?

Alkermes develops innovative medicines for alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder.

Where is Alkermes located?

Alkermes is headquartered in Dublin, Ireland, with facilities in Waltham, Massachusetts, Athlone, Ireland, and Wilmington, Ohio.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4